In this free webinar, learn about patient-centered approaches shaping ophthalmology trials, uniting stakeholders for better treatments and outcomes. The speakers will address advances in trial design specific to rare/genetic diseases of the eye, with a focus on cell and gene therapy, the need to work collaboratively in this space to match advanced therapeutic trial design to the unique needs of investigating ocular diseases and how new perspectives on patient centricity is leading to the evolution of these trials. Join this webinar to gain insights into how sponsors, service providers, investigator sites, caregivers and patient advocacy groups can work together to accelerate the pace of bringing new treatments to these patients, for better outcomes and improved quality of life.
TORONTO, Jan. 10, 2024 /PRNewswire-PRWeb/ -- Discover an informative webinar exploring patient-centered approaches shaping ophthalmology trials, uniting stakeholders for better treatments and outcomes. Clinical trials in ophthalmology require special considerations at every stage, including trial design, recruitment strategies, patient outreach and engagement, assessments and data collection and management of investigational products or devices.
The key to success is putting the patients and their caregivers at the center when considering the overall approach to the trial. This panel session is fortunate to include the father of a child affected by Leber hereditary optic neuropathy (LHON) and will open with the perspective of a parent and active patient advocate.
The speakers will address advances in trial design specific to rare/genetic diseases of the eye, with a focus on cell and gene therapy, the need to work collaboratively in this space to match advanced therapeutic trial design to the unique needs of investigating ocular diseases and how new perspectives on patient centricity is leading to the evolution of these trials.
Join this webinar to gain insights into how sponsors, service providers, investigator sites, caregivers and patient advocacy groups can work together to accelerate the pace of bringing new treatments to these patients, for better outcomes and improved quality of life.
Join Chris Marsh, Cofounder and Advocate, LHON Collective; and experts from , Darby Thomas, PhD, Scientific Director, Gene Therapies, Rare Diseases, Advanced Therapies and Pediatrics Team (RAPT); Marlene Brown, CPM, PMP, Director, Rare Diseases, Advanced Therapeutics and Pediatrics Team (RAPT); Hannah Simonds, Director, Patient Recruitment and Engagement; and Tanya Richardson, Executive Director, Strategic Delivery & Growth, Ophthalmology, for the on Tuesday, January 30, 2024, at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit
For information about hosting a webinar visit
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article